Fierce Pharma
Fierce Biotech
Fierce Healthcare
Fierce Life Sciences Events
Advertise
About Us
Biotech
Cell & Gene Therapy
Clinical Data
Venture Capital
Deals
Research
Medtech
Devices
Diagnostics
AI and Machine Learning
CRO
Special Reports
Trending Topics
Diabetes
Clinical Development
Biologics
Fierce 50
Special Report
Awards Gala
Resources
Fierce Events
Industry Events
Webinars
Podcasts
Whitepapers
Survey
Events
Subscribe
Trending T
Biotech
Cell & Gene Therapy
Clinical Data
Venture Capital
Deals
Research
Medtech
Devices
Diagnostics
AI and Machine Learning
CRO
Special Reports
Trending Topics
Diabetes
Clinical Development
Biologics
Fierce 50
Special Report
Awards Gala
Resources
Fierce Events
Industry Events
Webinars
Podcasts
Whitepapers
Survey
Events
Subscribe
Fierce Pharma
Fierce Biotech
Fierce Healthcare
Fierce Life Sciences Events
Advertise
About Us
Biotech
Biotech
Pentixapharm scores $22M in IPO to advance radiopharma trials
The stock debuted on the Frankfurt Stock Exchange this morning at 5.10 euros per share, resulting in a market capitalization of 126.5 million euros.
James Waldron
Oct 3, 2024 10:36am
Legend set to open Philadelphia cell therapy R&D site next year
Oct 3, 2024 8:50am
Sponsored
Market Insights: What’s Driving the Shift Toward FSP Models in Clinical Development?
Oct 2, 2024 8:00am
Kurma closes first $154M haul for biggest biotech fund yet
Oct 3, 2024 8:05am
Sponsored
Patient Access and Affordability: PhRMA shares how we can put patients first
Feb 12, 2024 8:00am
GigaGen garners up to $135M BARDA bucks to beat botulism
Oct 3, 2024 8:00am
